METTL3 inhibition-activated cGAS/STING axis enhances immunotherapy and PARP inhibitor sensitivity of lung carcinoma
Jiawang Zhou, Jiaxin He, Yunqing Lu, Cheng Yi, Xing Chang, Lijun Tao, Ke Zhong, Haisheng Zhang, Hongxin Niu, Xiansong Wang, Zhuojia Chen, Hongsheng Wang
This study shows that inhibiting METTL3 activates the cGAS/STING pathway, enhancing anti-tumor immunity and PARP inhibitor sensitivity in lung carcinoma.
Research · Jan 1, 2026Peer-reviewedCancer Biology